RDGL is becoming a powerhouse pet/cancer biotech, with its 2018 trackrecord of 100% cured cancer in 5 cats and a dog, documented and treated at Washington State University and University of Missouri, with state of the art labs and teams.
-i think what we are all missing here, is if human trails never even happened, well look at the above! And horses they said are next. So cornering the market in types of cancer cures are you kidding me we are two cent stock? Anyone please show me a $10 or $50 biotech who can factual claim the same.
But RDGL all along plans to then enter human trials.. But just as an animal/pet cancer curing company, well the valuations are extraordinary here in all ways from .02 to who knows how high to me. Everything else becomes extreme bonus.
-and best of all no more FDA approval needed for these animal procedures we are good to go and in last PR even the University of Missouri Veternairy Oncologists are already recommending the IsoPet treatment woooooooooo!